MEPHOTRAXE 7.5 (Methotrexate (7.5mg))

Product Description

MEPHOTRAXE 7.5mg Tablet is a pharmaceutical product utilized in the management of various cancers affecting different regions of the body. Additionally, it is indicated for the treatment of rheumatoid arthritis, severe and resistant psoriasis, and Crohn’s disease. The mechanism of action involves inhibiting the proliferation of abnormal cells and modulating immune system responses in autoimmune disorders. This medication can be administered as a standalone therapy or in conjunction with other drugs, depending on the guidance of a healthcare provider. It is crucial to adhere to the prescribed dosage to avoid potential serious adverse effects. The therapeutic benefits may not be immediately apparent and could take weeks or even months to manifest; therefore, discontinuation of the medication should only occur following a healthcare professional’s advice. Some of the frequently reported adverse reactions include ulcerative stomatitis, alopecia, decreased blood cell counts, elevated liver enzymes, nausea, and gastrointestinal discomfort. Patients may be advised to take folic acid to alleviate some of these side effects. If these symptoms persist or worsen, it is important to consult a physician, as there may be strategies to mitigate these effects. MEPHOTRAXE 7.5mg Tablet can compromise the body’s ability to combat infections and may lead to complications related to blood, liver, or renal function. Regular monitoring through blood tests and physical assessments is typically performed before and during treatment to identify any arising issues. Prior to initiation, individuals should inform their doctor about any gastrointestinal, hepatic, or renal concerns, as well as any concurrent medications being taken, which might interact with this treatment. This medication is contraindicated during pregnancy and lactation due to the potential risks to the fetus and nursing infant. Alcohol consumption should also be avoided as it may heighten the risk of hepatic injury.